Skip to main content
. 2017 Feb 15;10:397–404. doi: 10.2147/JPR.S123045

Table 1.

Pretreatment and demographic data

Variable Results
Group A Group B Between-group difference
Gender p=0.6998
 Male 98 114
 Female 102 86
Age (years) 43.74 (±9.73) 44.12 (±10.22) p=0.133
Height (cm) 166.91 (±9.23) 168.49 (±8.86) p=0.0824
Ethnicity p=0.314
 Asian 2 0
 Black 71 83
 Caucasian 90 86
 Mulatto 37 31
Pain location p=0.5112
 Back pain 125 127
 Hip pain 45 37
 Carpal tunnel syndrome 30 36
Overall diet p=0.415
 Good 72 61
 Moderate 87 99
 Poor 41 40
Alcohol consumption p=0.57
 None 63 72
 ≤2 drinks/day 82 73
 >2 drinks/day 55 55
Cigarette smoking p=0.102
 Non-smoker 91 78
 <10 cigarettes/day 54 47
 ≥10 cigarettes/day 55 75
Manual labor p=0.309
 Light 57 68
 Moderate 69 56
 Heavy 74 76
Physical exercise p=0.415
 Regular (at least 1×/week) 49 41
 Irregular 81 77
 None 70 82

Notes: Data are n, or mean (±standard deviation). Group A: subjects treated with uridine, cytidine, and vitamin B12. Group B: subjects treated with vitamin B12 alone.